Cargando…

Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population

BACKGROUND AND OBJECTIVES: Gender-related differences in health care utilization for atrial fibrillation (AF) are increasingly recognized. However, large cohort data for examining gender-related differences in AF are lacking in Asian populations. METHODS: The Registry for Comparison Study of Drugs f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung Myung, Kim, Tae-Hoon, Cha, Myung-Jin, Park, Junbeom, Park, Jin-Kyu, Kang, Ki-Woon, Shim, Jaemin, Uhm, Jae-Sun, Kim, Jun, Park, Hyung Wook, Lee, Young Soo, Choi, Eue-Keun, Kim, Chang-Soo, Joung, Boyoung, Kim, Jin-Bae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986752/ https://www.ncbi.nlm.nih.gov/pubmed/29856147 http://dx.doi.org/10.4070/kcj.2017.0389

Ejemplares similares

Current Anticoagulant Usage Patterns and Determinants in Korean Patients with Nonvalvular Atrial Fibrillation
por: Ha, Hyun Su, et al.
Publicado: (2020)

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
por: Kim, Hyeongsoo, et al.
Publicado: (2020)

Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry
por: Kim, Hyeongsoo, et al.
Publicado: (2017)

Comparative occurrence of ischemic stroke with the rhythm versus rate control strategy in a national prospective cohort of atrial fibrillation
por: Kim, Jae Guk, et al.
Publicado: (2021)

Comparison of Rhythm and Rate Control Strategies for Stroke Occurrence in a Prospective Cohort of Atrial Fibrillation Patients
por: Choi, Yu Jeong, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc score predicts exercise intolerance in young and middle-aged male patients with asymptomatic atrial fibrillation
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
por: Cho, Min Soo, et al.
Publicado: (2021)

The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)
por: Cho, Seunghoon, et al.
Publicado: (2020)

Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants
por: Kim, Minjeong, et al.
Publicado: (2022)

Rhythm Control and Cardiovascular or Cerebrovascular Outcomes in Patients with Atrial Fibrillation: A Study of the CODE-AF Registry
por: Chung, Ho-Gi, et al.
Publicado: (2023)

Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)
por: Song, Shinjeong, et al.
Publicado: (2022)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
por: Uhm, Jae‐Sun, et al.
Publicado: (2021)

Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
por: Park, Hanjin, et al.
Publicado: (2023)

2018 Korean Guideline of Atrial Fibrillation Management
por: Joung, Boyoung, et al.
Publicado: (2018)

Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality‐of‐Life Score: The CODE‐AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry
por: Kim, Ju Youn, et al.
Publicado: (2022)

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
por: Jung, Byung Chun, et al.
Publicado: (2015)

Prevalence and Predictors of Clinically Relevant Atrial High-Rate Episodes in Patients with Cardiac Implantable Electronic Devices
por: Kim, Min, et al.
Publicado: (2020)

Characteristics of Pulmonary Vein Enlargement in Non-Valvular Atrial Fibrillation Patients with Stroke
por: Lee, Jung Myung, et al.
Publicado: (2014)

Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus
por: Lee, Kyuhyun, et al.
Publicado: (2023)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Prolonged PR Interval Predicts Clinical Recurrence of Atrial Fibrillation After Catheter Ablation
por: Park, Junbeom, et al.
Publicado: (2014)

Associations of Abdominal Obesity and New‐Onset Atrial Fibrillation in the General Population
por: Baek, Yong‐Soo, et al.
Publicado: (2017)

Artificial intelligence predicts clinically relevant atrial high-rate episodes in patients with cardiac implantable electronic devices
por: Kim, Min, et al.
Publicado: (2022)

Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)
por: Park, Junbeom, et al.
Publicado: (2022)

Prognostic Implications of Right and Left Atrial Enlargement after Radiofrequency Catheter Ablation in Patients with Nonvalvular Atrial Fibrillation
por: Moon, Jeonggeun, et al.
Publicado: (2015)

Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation
por: Kim, Tae‐Hoon, et al.
Publicado: (2016)

Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2023)

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
por: Kim, Hyue Mee, et al.
Publicado: (2019)

eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation
por: Shim, Jaemin, et al.
Publicado: (2015)

A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke
por: Park, Junbeom, et al.
Publicado: (2017)

Clinical Significance of Additional Ablation of Atrial Premature Beats after Catheter Ablation for Atrial Fibrillation
por: Kim, In-Soo, et al.
Publicado: (2016)

Low Left Atrial Compliance Contributes to the Clinical Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Structurally and Functionally Normal Heart
por: Park, Junbeom, et al.
Publicado: (2015)

Association between Atrial Fibrillation, Myocardial Infarction, Heart Failure and Mortality in Patients with Nontuberculous Mycobacterial Infection: a nationwide population-based study
por: Park, Chan Soon, et al.
Publicado: (2019)

Genome-wide association study-based prediction of atrial fibrillation using artificial intelligence
por: Kwon, Oh-Seok, et al.
Publicado: (2022)

Clinical Outcomes of Computational Virtual Mapping-Guided Catheter Ablation in Patients With Persistent Atrial Fibrillation: A Multicenter Prospective Randomized Clinical Trial
por: Baek, Yong-Soo, et al.
Publicado: (2021)

Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry
por: Park, Hee‐Soon, et al.
Publicado: (2019)

Junctional bradycardia is a potential risk factor of stroke
por: Kim, Gwang Sil, et al.
Publicado: (2016)

Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients
por: Choi, Eue‐Keun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sbcpoud47jgtpcbdju3osqhd2p